
Myriad Genetics
A leading personalized medicine company dedicated to being a trusted advisor transforming patients' lives worldwide with pioneering molecular diagnostics..
Market cap
$485m
Enterprise value
$551m
Share price
$5.31 MYGN
Recent deals
Authorizing premium user...